Acceptability Study on Nutricomp® Drink Plus Fibre in Adults (Fuchsia)

August 10, 2017 updated by: B. Braun Melsungen AG
Required for Advisory Committee for Borderline Substances (ACBS) approval. Aim of this study is to access the palatability, compliance and GI-tolerance of Nutricomp® Drink Plus Fibre to show that it is acceptable for patients in the United Kingdom.

Study Overview

Study Type

Interventional

Enrollment (Actual)

19

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Leigh On Sea, United Kingdom, SS9 3AA
        • AC Health & Nutrition Ltd

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  • Male and female participants ≥ 18 years of age
  • Assessed to have malnutrition or be at risk of malnutrition by a Dietician within the investigator team. Assessment to include, but not limited to weight loss history, current BMI/MUST score, anamnesis, dietary intake history and predicted future oral intake.
  • Anticipated period of nutritional support ≥ 12 days
  • Patient has the capacity and is willing to provide informed consent.

Exclusion criteria:

  • Participants with mental in capabilities who are unable to give informed consent
  • Hypersensitivity to any of the active substances or excipients within the IP
  • Severely impaired gastrointestinal function or complete failure
  • More than 50% of nutrition from Parenteral Nutrition
  • Simultaneous participation in another interventional study
  • Participants who are unwilling or mentally and/or physically unable to adhere to study procedures
  • Participants with dysphagia requiring thickened fluids
  • Participants with significant renal impairment (CKD)
  • Pregnancy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Nutricomp Drink Plus Fibre
Nutricomp® Drink Plus Fibre (flavours vanilla, coffee, peach-apricot and chocolate)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Occurrence of gastrointestinal tolerance parameters
Time Frame: Day 1 - day 13
Day 1 - day 13

Secondary Outcome Measures

Outcome Measure
Time Frame
Occurrence of (further) adverse events during the treatment period (yes/no, if yes timing/duration/assumed cause/seriousness/severity)
Time Frame: Day 1 - day 13
Day 1 - day 13
Palatability evaluation performed under controlled condition using a questionnaire with a 5 point hedonic scale rang
Time Frame: Day 1 - day 13
Day 1 - day 13

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2016

Primary Completion (ACTUAL)

December 1, 2016

Study Completion (ACTUAL)

December 1, 2016

Study Registration Dates

First Submitted

December 19, 2016

First Submitted That Met QC Criteria

January 5, 2017

First Posted (ESTIMATE)

January 9, 2017

Study Record Updates

Last Update Posted (ACTUAL)

August 11, 2017

Last Update Submitted That Met QC Criteria

August 10, 2017

Last Verified

January 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • HC-G-H-1610

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adult Patients in Need of High-energy Oral Nutritional Supplementation

Clinical Trials on Nutricomp Drink Plus Fibre

3
Subscribe